4//SEC Filing
Riley Brigit 4
Accession 0001209191-23-019841
CIK 0001501756other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 6:02 PM ET
Size
5.1 KB
Accession
0001209191-23-019841
Insider Transaction Report
Form 4
Riley Brigit
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-03-15$0.78/sh−7,299$5,705→ 117,435 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units.
- [F2]Includes 6,000 shares purchased on November 18, 2022 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, as amended and restated.
Documents
Issuer
Adverum Biotechnologies, Inc.
CIK 0001501756
Entity typeother
Related Parties
1- filerCIK 0001882857
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 6:02 PM ET
- Size
- 5.1 KB